Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044642 · ClinicalTrials.gov registry record · Phase 4
Lorazepam-Induced Toxicity in the Aged
A Phase 4 study, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
NCT00044642 is a Phase 4 study that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 90 participants.
The verdict
NCT00044642, a Phase 4 study, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study will compare the effects of an acute dose of lorazepam to a placebo in elderly patients with generalized anxiety disorder (GAD).
Interventions
- DRUG Lorazepam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2000-12 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00044642
The ClinicalTrials.gov registry entry for NCT00044642 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lorazepam is the first listed.
NCT00044642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00044642 about?
NCT00044642 is a clinical study titled "Lorazepam-Induced Toxicity in the Aged". This study will compare the effects of an acute dose of lorazepam to a placebo in elderly patients with generalized anxiety disorder (GAD).
What is the current status of trial NCT00044642?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2000-12. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00044642?
The interventions under investigation include: Lorazepam (DRUG).
Who is sponsoring clinical trial NCT00044642?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.